Vanguard Global Advisers’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
SVCM
KCM
Vanguard Global Advisers's XFOR Position: Q3 2026 in Review
Vanguard Global Advisers increased its X4 Pharmaceuticals (XFOR) stake by 1.3% in Q3 2026, buying an estimated $1.61K and bringing the position to 33,393 shares worth $96.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.
Vanguard Global Advisers first reported a position in XFOR in Q1 2026 and has held it in 3 quarters since. The position peaked at $154K in Q2 2026. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- Vanguard Global Advisers held 33,393 shares of X4 Pharmaceuticals worth $96.8K as of Q3 2026.
- Vanguard Global Advisers bought 416 X4 Pharmaceuticals shares in Q3 2026, an estimated $1.61K.
- X4 Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2789 holding.
- Vanguard Global Advisers first reported a position in X4 Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's X4 Pharmaceuticals position peaked at $154K in Q2 2026.
- 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.